| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 173.43B | 192.14B | 198.20B | 182.43B | 161.29B |
| Gross Profit | 47.84B | 51.60B | 50.80B | 47.31B | 55.65B |
| EBITDA | -15.51B | 329.02M | 30.50B | 1.02B | 4.05B |
| Net Income | -23.40B | -4.35B | 1.38B | -831.80M | 10.08B |
Balance Sheet | |||||
| Total Assets | 716.54B | 796.53B | 808.39B | 806.38B | 806.28B |
| Cash, Cash Equivalents and Short-Term Investments | 212.33B | 133.09B | 133.27B | 150.38B | 166.93B |
| Total Debt | 225.90B | 241.86B | 233.57B | 245.92B | 257.87B |
| Total Liabilities | 548.17B | 598.99B | 599.81B | 607.30B | 603.16B |
| Stockholders Equity | 93.87B | 118.10B | 124.94B | 120.73B | 131.00B |
Cash Flow | |||||
| Free Cash Flow | 15.42B | 15.61B | -3.35B | -5.45B | -9.64B |
| Operating Cash Flow | 26.59B | 26.88B | 9.82B | 1.76B | -3.32B |
| Investing Cash Flow | -61.13B | -126.97M | 17.59B | 35.58B | -536.96M |
| Financing Cash Flow | -15.25B | -14.27B | -39.67B | -38.12B | -3.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$22.65B | 2.84 | 6.12% | 5.00% | 2.39% | 7.81% | |
67 Neutral | HK$104.02B | 10.05 | 1.14% | 5.26% | 10.37% | -29.03% | |
66 Neutral | HK$383.99B | 5.51 | 5.53% | 5.15% | 2.24% | 1.42% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$275.95B | 17.13 | 2.12% | 4.02% | -0.47% | -30.71% | |
60 Neutral | HK$39.55B | 5.44 | 5.66% | 4.94% | 3.77% | -1.53% | |
51 Neutral | HK$32.38B | -0.33 | -21.69% | 0.44% | -9.73% | -443.25% |